share_log

4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Dogan Timur

4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Dogan Timur

4/A:持股变动声明(修正)-高管 Dogan Timur
美股SEC公告 ·  2024/09/24 04:29

牛牛AI助手已提取核心信息

Cardio Diagnostics Holdings, Inc. (CDIO.US) reported that its Chief Technology Officer, Dogan Timur, completed a purchase of company stock on September 6, 2024. The transaction involved the acquisition of 68,965 shares of common stock at a price of $0.29 per share. Following this transaction, Timur's direct holdings in the company increased to a total of 197,310 shares. The transaction is part of an open market or private purchase, as per the announcement.
Cardio Diagnostics Holdings, Inc. (CDIO.US) reported that its Chief Technology Officer, Dogan Timur, completed a purchase of company stock on September 6, 2024. The transaction involved the acquisition of 68,965 shares of common stock at a price of $0.29 per share. Following this transaction, Timur's direct holdings in the company increased to a total of 197,310 shares. The transaction is part of an open market or private purchase, as per the announcement.
心脏诊断控股公司(CDIO.US)报告称,其首席技术官多甘·蒂穆尔于2024年9月6日完成了对公司股票的购买。该交易涉及以每股0.29美元的价格收购了68,965股普通股。在此交易之后,蒂穆尔在公司的直接持股增加至总共197,310股。根据公告,该交易是市场公开交易或私人购买的一部分。
心脏诊断控股公司(CDIO.US)报告称,其首席技术官多甘·蒂穆尔于2024年9月6日完成了对公司股票的购买。该交易涉及以每股0.29美元的价格收购了68,965股普通股。在此交易之后,蒂穆尔在公司的直接持股增加至总共197,310股。根据公告,该交易是市场公开交易或私人购买的一部分。

译文内容由第三方软件翻译。


牛牛AI助手部分由第三方人工智能模型基于资讯内容自动生成。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。